Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C

Journal of Hepatology

Volumn 46, Issue 5, 2007, Pages 775-782

  Leroy, Vincent ^a,b   Hilleret, Marie Noëlle ^a   Sturm, Nathalie ^a   Trocme, Candice ^c   Renversez, Jean Charles ^a   Faure, Patrice ^a   Morel, Françoise ^c   Zarski, Jean Pierre ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b CEA GRENOBLE   (France)

^c Laboratoire d'Enzymologie   (France)

Author keywords

APRI; Fibrometer; Fibrosis; Fibrotest; Metalloproteinase; METAVIR; PIIINP

Indexed keywords

ARTICLE; CHRONIC HEPATITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ADULT; ALANINE TRANSAMINASE; ALGORITHMS; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOLOGICAL MARKERS; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 34047173013     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.12.013     Document Type: Article

References (27)

1. Strader D.B., Wright T., Thomas D.L., and Seeff L.B. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
2. Cadranel J.F., Rufat P., and Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the group of epidemiology of the french association for the study of the liver (AFEF). Hepatology 32 (2000) 477-481
3. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
4. Rousselet M.C., Michalak S., Dupre F., Croue A., Bedossa P., Saint-Andre J.P., and Cales P. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41 (2005) 257-264
5. McHutchison J.G., Blatt L.M., de Medina M., Craig J.R., Conrad A., Schiff E.R., and Tong M.J. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus interferon study group. J Gastroenterol Hepatol 15 (2000) 945-951
6. Croquet V., Vuillemin E., Ternisien C., Pilette C., Oberti F., Gallois Y., Trossaert M., Rousselet M.C., Chappard D., and Cales P. Prothrombin index is an indirect marker of severe liver fibrosis. Eur J Gastroenterol Hepatol 14 (2002) 1133-1141
7. Patel K., Gordon S.C., Jacobson I., Hezode C., Oh E., Smith K.M., Pawlotsky J.M., and McHutchison J.G. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 41 (2004) 935-942
8. Sud A., Hui J.M., Farrell G.C., Bandara P., Kench J.G., Fung C., Lin R., Samarasinghe D., Liddle C., McCaughan G.W., and George J. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology 39 (2004) 1239-1247
9. Rosenberg W.M., Voelker M., Thiel R., Becka M., Burt A., Schuppan D., Hubscher S., Roskams T., Pinzani M., and Arthur M.J. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127 (2004) 1704-1713
10. Lok A.S., Ghany M.G., Goodman Z.D., Wright E.C., Everson G.T., Sterling R.K., Everhart J.E., Lindsay K.L., Bonkovsky H.L., Di Bisceglie A.M., Lee W.M., Morgan T.R., Dienstag J.L., and Morishima C. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 42 (2005) 282-292
11. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., and Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
12. Forns X., Ampurdanes S., Llovet J.M., Aponte J., Quinto L., Martinez-Bauer E., Bruguera M., Sanchez-Tapias J.M., and Rodes J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36 (2002) 986-992
13. Adams L.A., Bulsara M., Rossi E., DeBoer B., Speers D., George J., Kench J., Farrell G., McCaughan G.W., and Jeffrey G.P. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 51 (2005) 1867-1873 Epub 2005 July 28
14. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., and Lok A.S. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
15. Cales P., Oberti F., Michalak S., Hubert-Fouchard I., Rousselet M.C., Konate A., Gallois Y., Ternisien C., Chevailler A., and Lunel F. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42 (2005) 1373-1381
16. Leroy V., Monier F., Bottari S., Trocme C., Sturm N., Hilleret M.N., Morel F., and Zarski J.P. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 99 (2004) 271-279
17. Trocme C., Leroy V., Sturm N., Hilleret M.N., Bottari S., Morel F., and Zarski J.P. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared to MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon alpha and ribavirin. J Viral Hepat 13 (2006) 643-651
18. Lackner C., Struber G., Liegl B., Leibl S., Ofner P., Bankuti C., Bauer B., and Stauber R.E. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 41 (2005) 1376-1382
19. Le Calvez S., Thabut D., Messous D., Munteanu M., Ratziu V., Imbert-Bismut F., and Poynard T. The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C. Hepatology 39 (2004) 862-863 author reply 863
20. Thabut D., Simon M., Myers R.P., Messous D., Thibault V., Imbert-Bismut F., and Poynard T. Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology 37 (2003) 1220-1221 author reply 1221
21. Poynard T., Imbert-Bismut F., Munteanu M., Messous D., Myers R.P., Thabut D., Ratziu V., Mercadier A., Benhamou Y., and Hainque B. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 3 (2004) 8
22. Poynard T., Munteanu M., Imbert-Bismut F., Charlotte F., Thabut D., Le Calvez S., Messous D., Thibault V., Benhamou Y., Moussalli J., and Ratziu V. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 50 (2004) 1344-1355 Epub 2004 June 10
23. Halfon P., Bourliere M., Deydier R., Botta-Fridlund D., Renou C., Tran A., Portal I., Allemand I., Bertrand J.J., Rosenthal-Allieri A., Rotily M., Sattonet C., Benderitter T., Saint Paul M.C., Bonnot H.P., Penaranda G., Degott C., Masseyeff M.F., and Ouzan D. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study. Am J Gastroenterol 101 (2006) 547-555
24. Regev A., Berho M., Jeffers L.J., Milikowski C., Molina E.G., Pyrsopoulos N.T., Feng Z.Z., Reddy K.R., and Schiff E.R. Sampling error and intra-observer variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97 (2002) 2614-2618
25. Colloredo G., Guido M., Sonzogni A., and Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39 (2003) 239-244
26. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., Darriet M., Couzigou P., and De Ledinghen V. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
27. Sebastiani G., Vario A., Guido M., Noventa F., Plebani M., Pistis R., Ferrari A., and Alberti A. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 44 (2006) 686-693 Epub 2006 February 8